Back to GL Glenview Capital Management, LLC
ABT
Showing 0 of 2 quarters
Position history for GLGlenview Capital Management, LLC's holdings in Abbott Laboratories
No. Glenview Capital Management exited its ABT (Abbott Laboratories) position in Q2 2020. Its Q1 2020 13F listed 46,752 shares worth $3.7M. Glenview Capital Management first reported ABT in Q1 2020 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.